Purchase Order 75D30119P04663
Award Date
5/7/19
Potential Completion Date
8/1/19
Potential Value
$147K
Federal Agency
CDC Pittsburgh
Awardee
XCR Diagnostics, Inc.
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
PSC Category
6640 - Laboratory Equipment And Supplies
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Salt Lake City, UT 84116, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Other Statutory Authority
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) awarded a $174,160.00 firm fixed price purchase order to XCR Diagnostics, Inc., a manufacturer of molecular diagnostic testing products, for the provision of CBOT singleplex assays and related laboratory supplies. This contract does not have a set-aside designation. XCR Diagnostics, Inc. is a subsidiary of Fluoresentric, Inc., another manufacturer of goods. The contract, awarded out of the CDC's...
This $151,410.00 firm fixed price purchase order was awarded to XCR Diagnostics, Inc., a manufacturer of molecular diagnostics testing products, by the Centers for Disease Control and Prevention (CDC) out of Pittsburgh, Pennsylvania. The contract is for the delivery of laboratory supplies including CBOT singleplex assays, which are used for disease diagnostic testing. This purchase order is not associated with any larger contract vehicle and does not have a set-aside designation. XCR...
XCR Diagnostics, Inc., a subsidiary of Fluoresentric, Inc., has been awarded a purchase order contract valued at two hundred eleven thousand seven hundred seventy-one dollars by the Centers for Disease Control and Prevention (CDC) located in Pittsburgh, Pennsylvania. The contract is for the delivery of a singleplex CBOT A assay to CDC's facility in Atlanta, Georgia. The firm fixed price contract runs from September 12, 2023 through October 30, 2023. No set aside designation or subcontractors...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $203,805.00 firm fixed price purchase order to XCR Diagnostics, Inc., a manufacturer of molecular diagnostics testing supplies, for laboratory reagents and supplies. This purchase order, which has no set-aside designation, will be performed in Salt Lake City, Utah and supports the CDC's diagnostic testing capabilities. XCR Diagnostics, Inc. is a wholly owned subsidiary of Fluoresentric, Inc.,...
This is a definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Fluoresentric, Inc., a manufacturer of goods registered to receive federal government awards. The contract, valued at $207,900.00, is for the provision of CBOT singleplex assays, which are laboratory reagents and diagnostic testing materials that support the CDC's mission of disease control and prevention. The contract has a firm fixed price pricing type and a performance period ending on August 7,...
This definitive contract was awarded by the Centers for Disease Control and Prevention (CDC) to Vela Diagnostics USA Inc. to purchase reagents and consumables for approximately $59,500. The CDC, a component of the Department of Health and Human Services, seeks to protect public health and safety through the control and prevention of disease, injury, and disability. This firm fixed price contract supports the CDC's mission and is being performed in Chamblee, Georgia through August 1, 2023. No set...
The Centers for Disease Control and Prevention, under the Department of Health and Human Services, awarded a $16,070 firm fixed price purchase order to Miscellaneous Foreign Awardees for HAIN LIFESCIENCE GENOTYPE LINE PROBE ASSAY KITS AND REAGENTS. Performance will take place in Germany from September 26, 2023 through October 16, 2023. The award is likely associated with CDC's infectious disease diagnostic testing and surveillance programs. No subcontractors or set aside designations were...
The Centers for Disease Control and Prevention (CDC) awarded a $93,496 purchase order to Roche Diagnostics Corporation for the delivery of Roche COBAS C6800/AMPLIPREP/CAPTAQ systems. This firm fixed price contract will provide the CDC's Pittsburgh location with laboratory equipment and supplies to support its disease testing and prevention efforts. Roche will deliver the requested products to the CDC site in Castleton, Indiana by October 25, 2023. No subcontractors or set aside designations were...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $205,470.00 firm-fixed-price delivery order contract to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, including tests for infectious diseases and genetic conditions. The contract, which is not set aside, is for the provision of reagents, test kits, instruments, and testing platforms to support the CDC's clinical diagnostic programs. Cepheid, as the prime contractor, has a...
The U.S. Centers for Disease Control and Prevention (CDC) awarded a $92,772.80 firm-fixed-price purchase order contract to Luminex Corporation, a manufacturer of biological testing technologies and diagnostic solutions. The contract does not have a set-aside designation. Luminex has previously provided immunology services, laboratory supplies, reagents, multiplexing equipment, maintenance, and diagnostic testing products to various federal agencies, including the CDC, Department of Veterans...